Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).
Clinical trial NCT01624636 · TERMINATED
Trial details
- NCT number
- NCT01624636
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2013-05-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.